KMT2D and acute myeloid leukemia: To prove the role of Ddit4 participated in the Kmt2d‐deficiency‐mediated hyperactivation of the mTOR pathway, we conduct a rescue experiment by overexpressing Ddit4 in Kmt2d‐deficient AML cells (Figure S4K, Supporting Information).